In terms of lung cancer, it has been suggested that high levels of DNA repair inhibiting proteins, such as SLFN11, and low levels of DNA repair promoting proteins, including ATM, may be a superior predictive biomarkers to BRCA1/2 mutations in small cell lung cancer (111, 112). The gene discussed is BRCA1; the disease is lung carcinoma.